Granahan Investment Management, LLC Spero Therapeutics, Inc. Transaction History

Granahan Investment Management, LLC

$2.38 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.74 - $7.44 $83,858 - $843,115	-113,322 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$7.87 - $15.15 $2.09 Million - $4.02 Million	-265,610 Reduced 70.09%	113,322 $986,000
Q4 2021 Feb 14, 2022	SELL	$13.09 - $18.77 $2.31 Million - $3.32 Million	-176,682 Reduced 31.8%	378,932 $6.07 Million
Q3 2021 Nov 15, 2021	BUY	$13.03 - $19.51 $2.91 Million - $4.35 Million	222,975 Added 67.03%	555,614 $10.2 Million
Q2 2021 Aug 16, 2021	SELL	$12.22 - $15.79 $115,772 - $149,594	-9,474 Reduced 2.77%	332,639 $4.64 Million
Q1 2021 May 17, 2021	SELL	$13.23 - $21.48 $1.03 Million - $1.68 Million	-78,207 Reduced 18.61%	342,113 $5.04 Million
Q4 2020 Feb 12, 2021	BUY	$11.65 - $22.07 $538,719 - $1.02 Million	46,242 Added 12.36%	420,320 $8.15 Million
Q3 2020 Nov 12, 2020	BUY	$8.96 - $14.12 $1.86 Million - $2.93 Million	207,472 Added 124.53%	374,078 $4.18 Million
Q2 2020 Aug 14, 2020	SELL	$7.27 - $14.18 $35,099 - $68,461	-4,828 Reduced 2.82%	166,606 $2.25 Million
Q1 2020 May 12, 2020	BUY	$5.27 - $10.41 $118,928 - $234,922	22,567 Added 15.16%	171,434 $1.39 Million
Q4 2019 Feb 14, 2020	BUY	$9.46 - $12.16 $12,525 - $16,099	1,324 Added 0.9%	148,867 $1.43 Million
Q3 2019 Nov 15, 2019	BUY	$9.01 - $12.55 $83,324 - $116,062	9,248 Added 6.69%	147,543 $1.56 Million
Q2 2019 Aug 14, 2019	SELL	$10.25 - $14.36 $22,867 - $32,037	-2,231 Reduced 1.59%	138,295 $1.59 Million
Q1 2019 May 14, 2019	SELL	$6.26 - $13.31 $86,262 - $183,411	-13,780 Reduced 8.93%	140,526 $1.8 Million
Q4 2018 Feb 13, 2019	SELL	$5.69 - $11.28 $15,658 - $31,042	-2,752 Reduced 1.75%	154,306 $949,000
Q3 2018 Nov 13, 2018	BUY	$9.69 - $17.79 $57,267 - $105,138	5,910 Added 3.91%	157,058 $1.65 Million
Q2 2018 Aug 15, 2018	BUY	$10.41 - $17.85 $1.57 Million - $2.7 Million	151,148 New	151,148 $2.22 Million

Others Institutions Holding SPRO

# of Institutions

Shares Held

13.9M

Call Options Held

200

Put Options Held

200

Anson Funds Management LP Dallas, TX

3.75M
Shares

$3.53 Million
0.6% of portfolio
Vanguard Group Inc Valley Forge, PA

1.76M
Shares

$1.66 Million
0.0% of portfolio
Atlas Venture Associates Ix, LLC Boston, MA

1.35M
Shares

$1.27 Million
14.54% of portfolio
Acadian Asset Management LLC Boston, MA

1.07M
Shares

$1.01 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

975K
Shares

$916,173
0.0% of portfolio

View Full List

About Spero Therapeutics, Inc.

Ticker SPRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,067,500
Market Cap $33M
Description
Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to ...

More about SPRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Granahan Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Granahan Investment Management, LLC with notifications on news.

Account